Adenocarcinoma of the esophagogastric junction: relationship between clinicopathological data and p53, cyclin D1 and Bcl-2 immunoexpressions

CONTEXT: Esophagogastric junction adenocarcinoma has an aggressive behavior, and TNM (UICC) staging is not always accurate enough to categorize patient's outcome. OBJECTIVES: To evaluated p53, cyclin D1 and Bcl-2 immunoexpressions in esophagogastric junction adenocarcinoma patients, without Bar...

ver descrição completa

Detalhes bibliográficos
Autor principal: Lehrbach,Dárcio Matenhauer (author)
Outros Autores: Cecconello,Ivan (author), Ribeiro Jr,Ulysses (author), Capelozzi,Vera Luiza (author), Ab'Saber,Alexandre Muxfeldt (author), Alves,Venâncio Avancini Ferreira (author)
Formato: article
Idioma:eng
Publicado em: 2009
Assuntos:
Esophagogastric junction
Stomach neoplasms
Esophageal neoplasms
Adenocarcinoma
Tumor suppressor protein p53
Cyclin D1
Proto-oncogene proteins c-bcl-2
Texto completo:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-28032009000400013
País:Brasil
Oai:oai:scielo:S0004-28032009000400013

Texto Completo

http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-28032009000400013

Registos relacionados